Nuveen Real Asset Income and Growth Fund Common Shares of Beneficial Interest (JRI)

FairStock Score: 45/100 — MIXED

Key Financials

Strengths

• Attractive 12.2% dividend yield providing steady income returns

Concerns

• Weak Piotroski F-Score of 0/9 suggests deteriorating financial quality across multiple dimensions
• Altman Z-Score of 0.8 places it in the financial distress zone—elevated bankruptcy risk

AI Analysis

Nuveen Real Asset Income and Growth Fund Common Shares of Beneficial Interest is a micro-cap financial services company valued at $355 million. From a quality standpoint, Nuveen shows weak Piotroski F-Score of 0/9 signaling deteriorating fundamentals and distressed Altman Z-Score of 0.8 warrants caution. On valuation, the stock is deeply undervalued on a P/E basis at 7.1x, with offers a 43% margin of safety vs Graham Number of $23. The 12.2% dividend yield adds an income component for patient holders. Our composite FairStock Score of 45/100 reflects mixed fundamentals overall. Investors should weigh the business quality against the current price and their own margin of safety requirements.

Bull Case

Improving fundamentals and sector tailwinds could drive meaningful earnings growth, compressing the effective multiple for patient investors. Operational leverage in the business model means incremental revenue growth could disproportionately boost bottom-line profitability.

Bear Case

Macro headwinds or sector-specific disruption could pressure margins, particularly if competitive intensity increases in the financial services space. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer